Skip to main content


In this episode, Larry Green, MD, interviews Seemal Desai, MD, about identifying and treating psoriasis in patients with skin of color, as well as what the field of dermatology can do to improve patient care and access for this patient population.
In this episode, Nathan Bowers, MD, reviews the role of the skin microbiome in atopic dermatitis and therapeutic options that target this aspect of the disease.
In this podcast, Ginette Okoye, MD, discusses important treatment considerations dermatologists should keep in mind when treating psoriasis in patients with skin of color.
In this podcast, Ted Rosen, MD, reviews the diagnosis and management of sexually transmitted diseases for dermatologists, as well as how the pandemic has impacted patients with STDs.
In this podcast, Valerie Callender, MD, discusses the pathogenesis and treatment options for central centrifugal cicatricial alopecia in women with skin of color.
In this episode, Dr Larry Green interviews Dr George Han about current and future oral small molecules for psoriasis.
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Ramiz Hamid, MD, reviews some of the newer therapeutic options in the pipeline for atopic dermatitis.
Larry Green, MD, interviews Esther Freeman, MD, about the latest findings from the COVID-19 Dermatology registry, including recent studies on COVID-19 long haulers and chilblains.
Mark Kaufmann, MD, and Larry Green, MD, discuss the 2021 bill code changes and what dermatologists need to know for the new year.
Back to Top